Electronic Health RecordsDP-CONCILNCT02071472
Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation
A study testing DP medication reconciliation in people with Electronic Health Records, run by University Hospital, Grenoble at 1 site in France.
Trial summary
The objective is to evaluate the impact of an electronic pharmaceutical record used for medication reconciliation by a pharmacist associated to the anesthesiologist consultation Experimental intervention: medication reconciliation by a pharmacist using an electronic pharmaceutical record before the anesthesiologist… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Electronic Health Records
- What is being tested?
- DP medication reconciliation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,076 participants
- Where
- 1 siteFrance
- Study dates
- Apr 2014to Feb 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- patient coming for anesthetics consultation before a planned surgery
- age above18
- available electronic pharmaceutical record (DP)
- at least one medication prescribed before hospital admission
Who cannot join
- Minor patients ou majors protected by law
- Not speaking French patient
- Person who are not free by law or administrative decision
Trial locations and contacts
1 site in 1 country.
France1 site
Pharmacy Department - University Hospital of Grenoble
Grenoble, Isère, 38043
About this study
Official title: Evaluation of the Impact of an Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation
The objective is to evaluate the impact of an electronic pharmaceutical record used for medication reconciliation by a pharmacist associated to the anesthesiologist consultation
Experimental intervention:
medication reconciliation by a pharmacist using an electronic pharmaceutical record before the anesthesiologist consultation for planned surgery patients. The clinical pharmacist communicates the recommendations regarding the drug therapy to the anesthesiologist orally and using a specific formulary.
Control intervention:
Conventional anesthesiologist consultation for planned surgery patients.
Read the detailed description
Anesthesiology consultation is mandatory in France for planned surgery. It is part of the concept of anesthesia safety. The main goal is to assess the anesthetic and surgical risk including clinical and drug features likely to interfere with the anesthesia. The medication reconciliation is a central part of this consultation especially in order to assess the allergic risk and hemostasis disorders.
However, access to comprehensive and reliable data concerning the consumption of health products by the patient represents a major challenge. The "Dossier Pharmaceutique" (DP) is an electronic pharmaceutical record including medications (prescribed medications, over the counter medications, complementary and alternative medicines) delivered by community pharmacists over a four month period. Hospital pharmacists have access to the DP of hospitalized patients in order to improve the quality of the medication reconciliation. These informations regarding medication of the patients will be shared with anesthesiologists.
- Conditions
- Electronic Health Records
- Being tested
- DP medication reconciliation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DP medication reconciliationOther
| Study group | Role | What they receive |
|---|---|---|
| DP medication reconciliation | Experimental | medication reconciliation by a pharmacist using an electronic pharmaceutical record associated to the anesthesiologist consultation for planned surgery patients. Receives: Other: DP medication reconciliation |
| control | No intervention | conventional anesthesiologist consultation for planned surgery patients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants with a potential or documented adverse drug event collected by using trigger tool method
Measured: within the first 30 days after surgery
Secondary outcomes (1)
Number of medications reported by the anesthesiologist in the medical record
Measured: winthin 2 to 4 weeks between anesthesiogist consultation and surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Feb 2014 (estimated)
- Study startApr 2014
- Primary completionOct 2015 (estimated)
- Study completionFeb 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Electronic Health RecordsStudies of the same condition, open and under way.
- More trials run by University Hospital, GrenobleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,076 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Grenoble
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Pierrick BEDOUCH, PharmD, PhD, Study chair, University Hospital, Grenoble
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02071472
- Sponsor's protocol ID
- DCIC 13 16
- Acronym
- DP-CONCIL
- Status last verified
- Apr 2014
- First submitted
- 28 Nov 2013
- Last updated
- 28 Apr 2014
- Results posted
- No
- Data monitoring committee
- No
Publications
Chapuis C, Bosson JL, Bardet JD, Lepelley M, Sourd D, Roustit M, Allenet B, Chanoine S, Albaladejo P, Bedouch P. Electronic pharmaceutical record for best possible medication history at preoperative evaluation to prevent postoperative adverse events: a quasi-experimental study. BMJ Open Qual. 2025 Mar 3;14(1):e003022. doi: 10.1136/bmjoq-2024-003022.
PubMed 40032596
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Impact of an Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation
- ClinicalTrials.gov ID
- NCT02071472
- Acronym / sponsor ID
- DP-CONCIL / DCIC 13 16
- Conditions
- Electronic Health Records
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1,076 participants (estimated)
- Lead sponsor
- University Hospital, GrenobleUniversity, hospital or other
- Study start
- Apr 2014
- Primary completion
- Oct 2015 (estimated)
- Study completion
- Feb 2016 (estimated)
- First posted
- 26 Feb 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective is to evaluate the impact of an electronic pharmaceutical record used for medication reconciliation by a pharmacist associated to the anesthesiologist consultation
Experimental intervention:
medication reconciliation by a pharmacist using an electronic pharmaceutical record before the anesthesiologist consultation for planned surgery patients. The clinical pharmacist communicates the recommendations regarding the drug therapy to the anesthesiologist orally and using a specific formulary.
Control intervention:
Conventional anesthesiologist consultation for planned surgery patients.
Detailed description
Anesthesiology consultation is mandatory in France for planned surgery. It is part of the concept of anesthesia safety. The main goal is to assess the anesthetic and surgical risk including clinical and drug features likely to interfere with the anesthesia. The medication reconciliation is a central part of this consultation especially in order to assess the allergic risk and hemostasis disorders.
However, access to comprehensive and reliable data concerning the consumption of health products by the patient represents a major challenge. The "Dossier Pharmaceutique" (DP) is an electronic pharmaceutical record including medications (prescribed medications, over the counter medications, complementary and alternative medicines) delivered by community pharmacists over a four month period. Hospital pharmacists have access to the DP of hospitalized patients in order to improve the quality of the medication reconciliation. These informations regarding medication of the patients will be shared with anesthesiologists.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| DP medication reconciliation | Experimental | Other: DP medication reconciliationmedication reconciliation by a pharmacist using an electronic pharmaceutical record associated to the anesthesiologist consultation for planned surgery patients. |
| control | No intervention | –conventional anesthesiologist consultation for planned surgery patients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- patient coming for anesthetics consultation before a planned surgery
- age above18
- available electronic pharmaceutical record (DP)
- at least one medication prescribed before hospital admission
Key exclusion criteria (3 listed)
- Minor patients ou majors protected by law
- Not speaking French patient
- Person who are not free by law or administrative decision
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DP medication reconciliation | Other | DP medication reconciliation |
Primary outcome
Number of participants with a potential or documented adverse drug event collected by using trigger tool method
Time frame: within the first 30 days after surgery
1 secondary outcome
Number of medications reported by the anesthesiologist in the medical record
Time frame: winthin 2 to 4 weeks between anesthesiogist consultation and surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2014.
- Derived from this study: PubMed 40032596Chapuis C, Bosson JL, Bardet JD, Lepelley M, Sourd D, Roustit M, Allenet B, Chanoine S, Albaladejo P, Bedouch P. Electronic pharmaceutical record for best possible medication history at preoperative evaluation to prevent postoperative adverse events: a quasi-experimental study. BMJ Open Qual. 2025 Mar 3;14(1):e003022. doi: 10.1136/bmjoq-2024-003022.
Related trials for Electronic Health Records
Enrolling by invitationObservational study
An Observational Post-Authorization Safety and Effectiveness Study of Ravulizumab in Adult Patients Aged 18 and Older Diagnosed With Paroxysmal Nocturnal Hemoglobinuria Using Multicenter Electronic Medical Records in South Korea
Hemoglobinuria, Paroxysmal
RecruitingObservational study
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Crohn Disease, Colitis, Ulcerative
RecruitingObservational study
Duchenne Electronic Health Record Study
Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy
RecruitingObservational study
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Cancer, Cancer Diagnosis
RecruitingObservational study
Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI)
Artificial Intelligence, Machine Learning
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pierrick BEDOUCH, PharmD, PhD study chair
University Hospital, Grenoble
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing DP medication reconciliation in people with Electronic Health Records, run by University Hospital, Grenoble at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants with a potential or documented adverse drug event collected by using trigger tool method (time frame: within the first 30 days after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02071472, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2014.